annual CFO:
-$176.53M-$154.10M(-686.97%)Summary
- As of today (September 18, 2025), CDTX annual cash flow from operations is -$176.53 million, with the most recent change of -$154.10 million (-686.97%) on December 31, 2024.
- During the last 3 years, CDTX annual CFO has fallen by -$151.30 million (-599.64%).
- CDTX annual CFO is now -16744.75% below its all-time high of -$1.05 million, reached on December 31, 2013.
Performance
CDTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$40.96M-$19.01M(-86.61%)Summary
- As of today (September 18, 2025), CDTX quarterly cash flow from operations is -$40.96 million, with the most recent change of -$19.01 million (-86.61%) on June 30, 2025.
- Over the past year, CDTX quarterly CFO has increased by +$62.82 million (+60.53%).
- CDTX quarterly CFO is now -246.43% below its all-time high of $27.97 million, reached on September 30, 2022.
Performance
CDTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$129.02M+$62.82M(+32.75%)Summary
- As of today (September 18, 2025), CDTX TTM cash flow from operations is -$129.02 million, with the most recent change of +$62.82 million (+32.75%) on June 30, 2025.
- Over the past year, CDTX TTM CFO has dropped by -$4.24 million (-3.40%).
- CDTX TTM CFO is now -31368.29% below its all-time high of -$410.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CDTX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -687.0% | +60.5% | -3.4% |
| 3 y3 years | -599.6% | -246.1% | -107.0% |
| 5 y5 years | -518.7% | -191.1% | -364.5% |
CDTX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -687.0% | at low | -246.4% | +60.5% | <-9999.0% | +32.8% |
| 5 y | 5-year | -687.0% | at low | -246.4% | +60.5% | <-9999.0% | +32.8% |
| alltime | all time | <-9999.0% | at low | -246.4% | +60.5% | <-9999.0% | +32.8% |
CDTX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$40.96M(+86.6%) | -$129.02M(-32.7%) |
| Mar 2025 | - | -$21.95M(-25.4%) | -$191.84M(+8.7%) |
| Dec 2024 | -$176.53M(+687.0%) | -$29.41M(-19.8%) | -$176.53M(+10.4%) |
| Sep 2024 | - | -$36.70M(-64.6%) | -$159.84M(+28.1%) |
| Jun 2024 | - | -$103.78M(+1462.0%) | -$124.78M(+586.4%) |
| Mar 2024 | - | -$6.64M(-47.8%) | -$18.18M(-19.0%) |
| Dec 2023 | -$22.43M(-21.2%) | -$12.72M(+678.6%) | -$22.43M(-27.0%) |
| Sep 2023 | - | -$1.63M(-157.9%) | -$30.71M(+2679.4%) |
| Jun 2023 | - | $2.82M(-125.9%) | -$1.10M(-93.0%) |
| Mar 2023 | - | -$10.90M(-48.1%) | -$15.76M(-44.6%) |
| Dec 2022 | -$28.47M(+12.8%) | -$21.00M(-175.1%) | -$28.47M(+27.2%) |
| Sep 2022 | - | $27.97M(-336.3%) | -$22.38M(-64.1%) |
| Jun 2022 | - | -$11.84M(-49.9%) | -$62.32M(+32.5%) |
| Mar 2022 | - | -$23.61M(+58.4%) | -$47.05M(+86.5%) |
| Dec 2021 | -$25.23M(-53.6%) | -$14.91M(+24.5%) | -$25.23M(+17.6%) |
| Sep 2021 | - | -$11.97M(-448.0%) | -$21.45M(-9.0%) |
| Jun 2021 | - | $3.44M(-291.9%) | -$23.56M(-42.6%) |
| Mar 2021 | - | -$1.79M(-83.9%) | -$41.08M(-24.5%) |
| Dec 2020 | -$54.41M(+90.7%) | -$11.13M(-21.0%) | -$54.41M(-7.0%) |
| Sep 2020 | - | -$14.08M(+0.1%) | -$58.48M(+110.5%) |
| Jun 2020 | - | -$14.07M(-7.0%) | -$27.78M(+4.8%) |
| Mar 2020 | - | -$15.13M(-0.5%) | -$26.51M(-7.1%) |
| Dec 2019 | -$28.53M | -$15.20M(-191.4%) | -$28.53M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $16.62M(-229.8%) | -$27.00M(-52.1%) |
| Jun 2019 | - | -$12.81M(-25.3%) | -$56.40M(-4.6%) |
| Mar 2019 | - | -$17.15M(+25.5%) | -$59.13M(+4.3%) |
| Dec 2018 | -$56.70M(+13.6%) | -$13.67M(+6.9%) | -$56.70M(+7.9%) |
| Sep 2018 | - | -$12.78M(-17.7%) | -$52.53M(-2.0%) |
| Jun 2018 | - | -$15.53M(+5.5%) | -$53.61M(+7.0%) |
| Mar 2018 | - | -$14.72M(+55.1%) | -$50.11M(+0.4%) |
| Dec 2017 | -$49.91M(+25.5%) | -$9.49M(-31.6%) | -$49.91M(-4.3%) |
| Sep 2017 | - | -$13.87M(+15.3%) | -$52.14M(+13.4%) |
| Jun 2017 | - | -$12.03M(-17.1%) | -$45.96M(+5.9%) |
| Mar 2017 | - | -$14.52M(+23.8%) | -$43.40M(+9.1%) |
| Dec 2016 | -$39.77M(+53.2%) | -$11.73M(+52.5%) | -$39.77M(+14.3%) |
| Sep 2016 | - | -$7.69M(-18.8%) | -$34.78M(+1.1%) |
| Jun 2016 | - | -$9.47M(-13.0%) | -$34.40M(+11.7%) |
| Mar 2016 | - | -$10.89M(+61.6%) | -$30.79M(+18.6%) |
| Dec 2015 | -$25.96M(+236.7%) | -$6.74M(-7.7%) | -$25.96M(+15.9%) |
| Sep 2015 | - | -$7.30M(+24.5%) | -$22.39M(+22.3%) |
| Jun 2015 | - | -$5.87M(-3.1%) | -$18.31M(+37.2%) |
| Mar 2015 | - | -$6.05M(+90.8%) | -$13.35M(+73.2%) |
| Dec 2014 | -$7.71M(+635.7%) | -$3.17M(-1.6%) | -$7.71M(+69.9%) |
| Sep 2014 | - | -$3.22M(+256.6%) | -$4.54M(+245.4%) |
| Jun 2014 | - | -$904.00K(+120.5%) | -$1.31M(+220.5%) |
| Mar 2014 | - | -$410.00K | -$410.00K |
| Dec 2013 | -$1.05M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual CFO year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Cidara Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM CFO year-on-year change?
What is Cidara Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of CDTX is -$176.53M
What is the all time high annual CFO for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual cash flow from operations is -$1.05M
What is Cidara Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, CDTX annual cash flow from operations has changed by -$154.10M (-686.97%)
What is Cidara Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of CDTX is -$40.96M
What is the all time high quarterly CFO for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly cash flow from operations is $27.97M
What is Cidara Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, CDTX quarterly cash flow from operations has changed by +$62.82M (+60.53%)
What is Cidara Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of CDTX is -$129.02M
What is the all time high TTM CFO for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM cash flow from operations is -$410.00K
What is Cidara Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, CDTX TTM cash flow from operations has changed by -$4.24M (-3.40%)